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NusG homologs regulate transcription and coupled
processes in all living organisms. The Escherichia
coli (E. coli) two-domain paralogs NusG and RfaH
have conformationally identical N-terminal domains
(NTDs) but dramatically different carboxy-terminal
domains (CTDs), a b barrel in NusG and an a hairpin
in RfaH. Both NTDs interact with elongating RNA
polymerase (RNAP) to reduce pausing. In NusG,
NTD and CTD are completely independent, and
NusG-CTD interacts with termination factor Rho or
ribosomal protein S10. In contrast, RfaH-CTD makes
extensive contacts with RfaH-NTD to mask an
RNAP-binding site therein. Upon RfaH interaction
with its DNA target, the operon polarity suppressor
(ops) DNA, RfaH-CTD is released, allowing RfaH-
NTD to bind to RNAP. Here, we show that the
released RfaH-CTD completely refolds from an all-a
to an all-b conformation identical to that of NusG-
CTD. As a consequence, RfaH-CTD binding to
S10 is enabled and translation of RfaH-controlled
operons is strongly potentiated.
INTRODUCTION
Regulators of the NusG family of proteins (Spt5 in yeast and
Archaea, DSIF in humans) comprise the only universally
conserved family of transcription factors (Werner and Groh-
mann, 2011). These proteins contain two common domains,
the N-terminal NGN domain and one (or several in eukaryotes)
C-terminal KOW domain, which are connected by a flexible
linker. The NTDs apparently play the same role in Bacteria
(E. coli), Archaea (Pyrococcus furiosus; Methanococcus janna-
schii), and Eukaryota (Saccharomyces cerevisiae) (Hirtreiter
et al., 2010; Klein et al., 2011; Martinez-Rucobo et al., 2011;Sevostyanova et al., 2011). They directly bind to RNAP and
modify it into a processive, pause-resistant state. Recent reports
suggest a conserved molecular mechanism: the NTD bridges
the gap between the two largest RNAP subunits and becomes
part of a processivity clamp that surrounds the nucleic acid
chains in the transcription elongation complex (TEC) (Hirtreiter
et al., 2010; Martinez-Rucobo et al., 2011; Sevostyanova et al.,
2011). The closed clamp is thought to disfavor TEC isomerization
into paused and termination states, thereby ensuring that RNAP
completes the synthesis of the nascent RNA. The presence of
a NusG-like factor in the last universal common ancestor (Werner
and Grohmann, 2011) underscores its importance for processive
transcription in all living organisms.
The CTDs of NusG-like proteins interact with diverse cellular
partners and may play very diverse and opposing roles, as
illustrated by the best-studied members of this family, E. coli
NusG and RfaH. NusG is associated with RNAPs transcribing
most operons (Mooney et al., 2009a) and assists a subset of
Rho termination events including termination of defective
mRNAs and spurious transcripts (Burns and Richardson,
1995); NusG-CTD interacts with termination factor Rho to induce
premature RNA release. In contrast, RfaH is only recruited to
horizontally transferred operons that contain a 12 nucleotide
(nt) operon polarity suppressor (ops) site located in their leader
regions (Belogurov et al., 2009). These operons encode biosyn-
thesis of lipopolysaccharide (LPS) core, O-antigen, capsules,
and hemolysin (Bailey et al., 1997) and are dramatically activated
by RfaH, which decreases strong Rho-mediated polarity, in part
by excluding NusG from RNAPs transcribing the ops-containing
operons (Belogurov et al., 2009; Burns et al., 1998; Sevostya-
nova et al., 2011).
Comparison of RfaH and NusG structures readily explains
their similarities and differences (Figure 1). The structurally
similar NTDs bind to the RNAP b0 clamp helices domain (Belo-
gurov et al., 2007; Mooney et al., 2009b) and increase the
elongation rate in vitro (Artsimovitch and Landick, 2000, 2002;
Burova et al., 1995), whereas the CTDs are conformational antip-
odes. In the crystal structure, RfaH-CTD folds as an a hairpinCell 150, 291–303, July 20, 2012 ª2012 Elsevier Inc. 291
Figure 1. Structures of NusG and RfaH
(A) Ribbon representation of NusG (NTD, light green,
PDB-ID: 2K06; CTD, green, PDB-ID: 2JVV; Mooney et al.,
2009b).
(B) Ribbon representation of full-length RfaH (NTD, light
blue; CTD, blue, PDB-ID: 2OUG (Belogurov et al., 2007),
with RfaH-CTD in an a-helical fold. Termini and linker
regions (broken lines) are labeled.that tightly binds RfaH-NTD, locking the protein in a ‘‘silent’’ state
by hiding the RNAP-binding surface of RfaH-NTD in the domain
interface (Belogurov et al., 2007). When transcribing RNAP
pauses at the ops site, interactions between RfaH-NTD, ops
bases in the nontemplate DNA strand, and RNAP appear to
trigger domain separation, thus ‘‘activating’’ RfaH. The isolated
RfaH-NTD mediates all characteristic effects of RfaH on tran-
scription elongation but no longer requires the ops site for
recruitment to the TEC (Belogurov et al., 2007). Thus, the only
known role of RfaH-CTD is to restrict RfaH action to ops-contain-
ing operons by masking its RNAP-binding surface.
NusG-CTD forms an antiparallel barrel-like b sheet (Mooney
et al., 2009b) that does not stably interact with NusG-NTD in
solution (Burmann et al., 2011), leaving the RNAP-binding site
exposed. The residues that interact with the ops element in
RfaH-NTD are not conserved in NusG-NTD (Belogurov et al.,
2010), which is consistent with NusG association with all E. coli
operons except those that contain ops (Belogurov et al., 2009).
Similarly to RfaH-NTD, isolated NusG-NTD reduces RNAP
pausing in vitro (Mooney et al., 2009b). However, NusG-CTD
plays a much more active role. It either interacts with Rho to
facilitate RNA release (Mooney et al., 2009b), binds to ribosomal
protein S10 (identical to NusE) to couple transcription and trans-
lation (Burmann et al., 2010), or mediates formation of an rRNA
antitermination complex (Squires and Zaporojets, 2000). A
similar domain architecture is observed in NusG and Spt5
proteins from many organisms (Martinez-Rucobo et al., 2011;
Mooney et al., 2009b; Reay et al., 2004; Steiner et al., 2002;
Zhou et al., 2009a), and the CTDs of these proteins interact
with diverse partners (Chen et al., 2009; Schneider et al., 2006;
Zhou et al., 2009b), suggesting that the b barrel conformation
is a preferred CTD state that facilitates linkage between tran-
scription and other key cellular processes.
Although a conformational change of this magnitude would be
unprecedented, several observations led us to propose that,
upon activation, RfaH-CTD may refold into a NusG-CTD-like
structure and interact with the ribosome (Belogurov et al.,
2009). First, the RfaH-CTD sequence can be easily integrated
into a b barrel structure (Belogurov et al., 2007). Second, RfaH-
CTD capture by the trailing ribosome could explain why RfaH
is stably bound to TEC in vivo, but not in vitro (Belogurov et al.,
2009). Third, RfaH effects on gene expression in vivo are much292 Cell 150, 291–303, July 20, 2012 ª2012 Elsevier Inc.larger than those on transcription in vitro
(Sevostyanova et al., 2011), suggesting the
influence of additional factors. Finally, RfaH
associates directly or indirectly with the transla-
tional machinery (Bailey et al., 2000). Here, we
show that RfaH-CTD can indeed switch itsprotein fold from all-a to all-b, enabling interactions with S10
and converting RfaH into a potent activator of translation.
RESULTS
Full-Length RfaH Maintains a Closed State in Solution
To test whether the RfaH-CTD exhibits different folds in the
crystal and in solution, we assigned the backbone atoms of the
full-length protein in solution nuclear magnetic resonance
(NMR) spectra. NMR 1H and 13C secondary chemical shifts
match the secondary structure elements of RfaH found in the
crystal structure (Figures 2A and 2B), and both RfaH-CTD helices
are well defined, ruling out an equilibrium of different RfaH-CTD
conformations in solution in the closed state. Nevertheless,
helix a4 appears to be one turn shorter in solution than in the
crystal, likely due to helix destabilization by G121. Chemical
shifts are close to random coil values for K102-G121, suggesting
high conformational flexibility, consistent with the lack of observ-
able electron density in the crystal structure. Backbone amide
resonances could not be detected for R11, G12, R40, R43,
T66, T67, R73, G82, and N156, which are all located in loop
regions in the crystal structure and may exhibit line broadening
due to fast solvent exchange in solution.
To test whether RfaH-NTD:RfaH-CTD interactions are
maintained in solution, we determined the rotational correlation
time tc for full-length RfaH.
15N transversal (R2) and longitudinal
(R1) relaxation rates at 18.8 T and 288 K (Figures 2C and 2D) were
R1 = 0.68 ± 0.12 s
1 and R2 = 31.8 ± 5.2 s
1 (excluding flexible
regions), thus tc = 13.4 ns for an isotropic model. These values
are characteristic for monomeric proteins the size of RfaH. The
R1/R2 distributions of RfaH-NTD and RfaH-CTD (Figure 2E)
suggest that both domains reorient with identical correlation
times, indicating tight domain interaction as in the crystal. Lower
R1/R2 ratios reflect subnanosecond flexibility for the linker
region. These results establish that the inactive RfaH conforma-
tion captured in the crystal is preserved in solution.
RfaH-CTD Refolds into a b Barrel upon Release
from RfaH-NTD
In [1H,15N] heteronuclear single-quantum coherence (HSQC)
spectra for isolated RfaH-CTD, we observed chemical shifts
differing significantly from those of the full-length protein
Figure 2. Structure of Full-Length RfaH in Solution
(A) Ribbon representation of the crystal structure. PDB-ID: 2OUG (Belogurov et al., 2007). NTD, light blue; CTD, blue. Termini and secondary structure elements
are labeled.
(B) Chemical shift index (CSI) for Ca and CO versus sequence position. Secondary structure elements as in (A).
(C) R1 for full-length RfaH.
(D) R2 for full-length RfaH.
(E) R1/R2 is unimodal for full-length RfaH. RfaH-CTD (124–158), blue bars; RfaH-NTD (1–100), light blue bars.(Figure S1 available online). Consistent with an all-a to all-b
rearrangement, the isolated RfaH-CTD does not contain any
helical structure but consists of five b strands, K115–I118,
Q127–F130, R138–N144, E149–K155, and F158–K160, which
form a well-defined antiparallel b sheet with strand order
b5-b1-b2-b3-b4 (Figures 3A and 3B and Table S1). Strikingly,
the folds of isolated RfaH-CTD and NusG-CTD are virtually
identical in solution (backbone root mean square deviation:
0.65 A˚ for P112–L162). The largest local structural difference
between the two CTDs is in the region corresponding to
E132–R138 in RfaH, which lacks interstrand contacts typical
for sheets, whereas the comparable region in NusG-CTD forms
strand b2. In RfaH, this region is 1 residue shorter and contains
P133, which has no equivalent in NusG. Thus, isolated, sepa-
rately expressed RfaH-CTD exists as a b barrel in solution. This
result predicts that RfaH-CTD completely refolds from the
a hairpin, stabilized by contacts with RfaH-NTD, when the do-
main interface is disrupted during RfaH recruitment to the TEC.Wenext askedwhether this dramatic structural rearrangement
can occur within the full-length protein. Because we were unable
to observe different folds of RfaH-CTDwithin the full-length RfaH
in solution, we tested conditions that were expected to destabi-
lize the NTD:CTD interface—specifically, elevated temperature
or presence of trifluoroethanol. Both led to immediate, complete
protein precipitation, most likely due to exposure of the large
nonpolar interdomain surface.
We next tried weakening the RfaH-NTD:RfaH-CTD interaction
while maintaining protein solubility by E48S substitution in
the full-length protein. This substitution is predicted to break
the salt bridge E48:R138 that connects the two domains. In the
[1H,15N]-HSQC spectrum of the E48S variant, we could clearly
observe signals of the RfaH-NTD and, simultaneously, a-helical
and b-barrel-type RfaH-CTD (Figures 4A and 4B). These results
demonstrate that the structural switch of RfaH-CTD may occur
within the full-length protein with destabilized interdomain
contacts. As evidenced by similar intensities of the peaksCell 150, 291–303, July 20, 2012 ª2012 Elsevier Inc. 293
Figure 3. Structural Transition of RfaH-CTD
(A) Ribbon diagram of a representative RfaH-CTD structure, residues 101–162; termini and secondary structure elements are labeled. Orientation relative to
Figure 1 is indicated.
(B) Ensemble of 20 accepted lowest energy structures. The flexible part, residues 101–107, is indicated.
(C) Ribbon representation of NusG-CTD (PDB-ID: 2JVV; Mooney et al., 2009b). Residues in the hydrophobic core of the CTD, sticks. Carbon, magenta; oxygen,
red; nitrogen, blue; sulfur, yellow.
(D) RfaH-CTD (PDB-ID: 2OUG; Belogurov et al., 2007) in the all-a-helical conformation; residues corresponding to the NusG-CTD core, magenta sticks. Within
the a-helical RfaH-CTD, these residues are scattered randomly along the helices (middle). For residues P110 and F159, no electron density could be determined
in the full-length protein (Belogurov et al., 2007); therefore, these are excluded. Domain opening leads to drastic refolding of RfaH-CTD (right) into an all-b-barrel
state; the residues corresponding to the NusG-CTD core also form the refolded RfaH-CTD core.
See also Table S1 and Figures S1 and S2.originating from a helix and b barrel, the two conformations of
RfaH-CTD in the E48S variant coexist in roughly 1:1 equilibrium.
As the E48S substitution is located in RfaH-NTD, it is not
expected to exert a direct effect on the conformation of RfaH-
CTD. However, to verify that RfaH-CTD can refold in a protein
with unmodified domains, we used an RfaH variant with a TEV
cleavage site engineered into the linker. The linker is highly flex-
ible and tolerates deletions and insertions (I.A., unpublished
data), and its sequence is not conserved (Carter et al., 2004);
thus, the functional properties of RfaH(NTD-TEV-CTD) are iden-
tical to those of wild-type (WT) RfaH (Figure 4C; Belogurov et al.,
2007). The linker nonetheless serves as a flexible tether that
restricts uncorrelated domain diffusion, thus enhancing the
collision probability of the two domains and stabilizing their inter-
actions. To induce domain separation, we added trace amounts
of TEV protease and recorded [1H,15N]-HSQC spectra. Initially,
we observed a spectrum typical for full-length RfaH, except for
additional signals from the seven residues of the TEV site in
the linker region, as expected. After incubation for 42 hr, we
were able to detect the signals of the RfaH-CTD in the b barrel
conformation. Simultaneously, signals for the a-helical RfaH-
CTD disappeared due to refolding, and signals for RfaH-NTD
were lost due to precipitation. The observed refolding rate is294 Cell 150, 291–303, July 20, 2012 ª2012 Elsevier Inc.likely limited by slow TEV-mediated cleavage of the linker under
our experimental conditions.
These results clearly demonstrate that RfaH-CTD refolds
spontaneously when released from RfaH-NTD. Because the
two domains must be separated to expose the RNAP-binding
site on RfaH-NTD, our observations strongly suggest that this
radical transformation occurs in the context of the WT protein
during transcription.
RfaH-CTD is able to adopt two entirely different structureswith
completely different internal amino acid contacts. In the domain-
closed form of RfaH, the large hydrophobic interdomain surface
(Belogurov et al., 2007) may foster denser packing of the RfaH-
CTD than would be possible in a b fold, whereas domain opening
allows refolding of the RfaH-CTD into a b fold and exposure of
the hydrophobic RfaH-NTD interdomain surface that also serves
as an RfaH-NTD:RNAP interface (Figure S2). Interestingly, the
hydrophobic RfaH-CTD interdomain residues are not present
exclusively in the hydrophobic core of the b barrel (Figure S2):
I129, L142, and I146 are outside of the barrel, whereas V116,
V154, and F159, the key residues of the RfaH-CTD’s hydro-
phobic core in b barrel conformation, are surface accessible or
are located in flexible regions in the a-helical conformation of
full-length, domain-closed RfaH (Figures 3C and 3D).
Figure 4. Structural Transition of RfaH-CTD in Full-Length RfaH
(A and B) Overlay of [1H,15N]-HSQC spectra of 15N-RfaH-E48S 45 mM, black; 15N-RfaH, 189 mM, cyan; and 15N-RfaH-CTD, 344 mM, red. Full spectra (A) and
enlargement of one region (B). Signals from the CTD in full-length RfaH (a-helical form), cyan; from the isolated CTD (b barrel form), red.
(C) Overlay of [1H,15N]-HSQC spectra of 15N-RfaH(NTD-TEV-CTD), 138 mM, black; 15N-RfaH, 189 mM, cyan; and 15N-RfaH(NTD-TEV-CTD) after incubation
with 1.75 mM TEV protease for 42 hr, 127 mM, red.
(D) Overlay of [1H,15N]-HSQC spectra of 15N-RfaH(NTD-TEV-CTD) 127 mM, red. After incubation with 1.75 mMTEV protease for 42 hr from (C) and 15N-RfaH-CTD,
344 mM, black; signals of the isolated CTD in the b barrel conformation, red.
See also Figures S3 and S4.Functional Role for RfaH-CTD Refolding
Prior to engagement with transcribing RNAP, the a hairpin RfaH-
CTD interacts with RfaH-NTD to restrict RfaH action to ops-
containing operons, avoiding interference with gene regulation
by housekeeping NusG (Belogurov et al., 2009). In NusG, as
well as in its archaeal and eukaryotic homologs, the b barrel
establishes functional interactions with diverse cellular targets.
To address the impact of RfaH-CTD refolding, we wanted to
determine whether it merely enables formation of a more stableb barrel or plays a further role in the control of gene expression
by RfaH.
Expression of the distal genes in an RfaH-dependent rfb
operon is nearly abolished by Rho in a DrfaH strain, suggesting
that the rfb operon is poorly translated; indeed, it displays a
very high fraction of rare codons and lacks a strong transla-
tion-initiation signal (Figure S3). RfaH restores expression of
distal genes, e.g., wbbI (Sevostyanova et al., 2011), but does
not prevent Rho association throughout the rfb operonCell 150, 291–303, July 20, 2012 ª2012 Elsevier Inc. 295
(Belogurov et al., 2009). RfaH could inhibit Rho activity by: (1)
modifying the TEC properties; (2) excluding NusG from RNAP,
thereby inhibiting Rho-mediated RNA release (but not Rho
recruitment, which is unaffected by NusG); (3) binding to Rho
in an unproductive fashion; or (4) increasing translation. Our
previous data are consistent with the first two mechanisms
(Belogurov et al., 2009; Sevostyanova et al., 2011).
We next asked whether b barrel RfaH-CTD could interact
with Rho (Figure S4) similarly to NusG-CTD (Mooney et al.,
2009b). The [1H,15N]-HSQC spectrum of 15N-labeled RfaH-
CTD showed no significant changes on titration with unlabeled
Rho, indicating that RfaH-CTD does not bind to Rho under
conditions in which NusG-CTD forms a Rho complex. As no
structural data for the NusG-CTD:Rho complex are available,
a detailed explanation of this difference is impossible. Mutagen-
esis and biochemical data, however, indicate that the loops
between strands b1/b2 and b3/b4 are essential for NusG:Rho
interactions because deletions in these regions abrogate
complex formation as assayed by in vitro pull-down experiments
(Chalissery et al., 2011). Several point mutations in these regions
affect Rho termination efficiency; among these are L158Q,
S163F, and G166D in NusG (Chalissery et al., 2011; Mooney
et al., 2009b; Sullivan et al., 1992), which correspond to S139,
N144, and N147, respectively, in RfaH. The different characteris-
tics of these residues may explain the inability of RfaH to interact
with Rho.
The dramatic RfaH effect on Rho-mediated polarity in vivo
(Sevostyanova et al., 2011), as compared with a modest effect
in vitro (Belogurov et al., 2009), and the lack of strong ribo-
some-binding sites (RBS) preceding the first open reading
frame (ORF) in RfaH-regulated operons led us to ask whether
RfaH recruits the ribosome in the absence of a strong RBS via
interaction between S10 and b barrel RfaH-CTD as with NusG
(Burmann et al., 2010), facilitating transcription-translation
coupling.
Efficient translation may confer sufficient protection against
Rho to obviate any role of RfaH in transcription-translation
coupling; conversely, inhibiting translation would confer depen-
dence on RfaH. To test these ideas, we used reporters in which
a lux operon is positioned downstream from an ops element. In
the presence of a strong RBS in front of the first luxC gene,
RfaH increases luciferase signal more than 6-fold (Belogurov
et al., 2010). Removal of RfaH-CTD further increased expression
1.4-fold (Figure 5A), likely because isolated NTD can be
recruited to RNAP at multiple sites, in contrast to WT RfaH that
becomes engaged only at an ops element. Alterations that
compromise RfaH binding to the TEC decrease luciferase
activity of this reporter (Belogurov et al., 2010); this pattern is
consistent with principal effects on transcription.
To test whether compromised translation would increase
dependence on RfaH, we removed the luxC RBS. This change
eliminated lux expression in the absence of RfaH (Figure 5B).
However, WT RfaH expressed from a plasmid increased lucif-
erase activity 1,000-fold, restoring it to 18% of that observed
with an RBS. This suggests that RfaH can indeed connect ribo-
somes to TECs and thereby couple translation to transcription. If
this interpretation were correct, stimulation of luciferase activity
should be dependent on RfaH-CTD. Indeed, the RfaH-CTD296 Cell 150, 291–303, July 20, 2012 ª2012 Elsevier Inc.deletion reduced lux expression in the absence of RBS more
than 6-fold (Figure 5B).
The stimulatory effect of RfaH-NTD alone was also more
pronounced in the absence of RBS. This difference is likely
due to a greater dependence on the anti-Rho activity of NTD
when translation is compromised and Rho can access the
nascent RNA. In the presence of the RBS, Rho action will be
inhibited by translation, reducing the requirement for RfaH-NTD.
These results suggest that destabilization of the interdomain
interface in full-length RfaH will augment its effect on gene
expression because the effects of RfaH-NTD and RfaH-CTD
will be combined. To test this prediction, we constructed an
E48A substitution that would be expected to disrupt the interdo-
main contacts, but not RfaH binding to RNAP. Indeed, we found
that E48A protein was highly active in reducing RNAP pausing
in vitro in the absence of an ops site, mimicking the effect of
the RfaH-CTD deletion (Figure S5); consistently, a substitution
for Ser induced RfaH-CTD refolding (Figure 4). In contrast to
the isolated RfaH-NTD, the E48A variant increased reporter
activity in vivo (Figures 5A and 5B); the E48A variant was
4-fold more active than the WT RfaH in the absence of RBS.
These results are consistent with the direct role of the refolded
RfaH-CTD in stimulation of lux operon translation.
NusG:S10 interactions are mediated by hydrophobic residues
(Burmann et al., 2010), some of which are conserved in the RfaH-
CTD (Figures S6A–S6C). NusG F165 (I146 in RfaH) is critical for
this interaction, is highly conserved (Burmann et al., 2010), is
required for viability (Knowlton et al., 2003), and is crucial for
NusG:S10 interactions in vivo (Mooney et al., 2009b). RfaH
I146D substitution (to eliminate putative van der Waals contacts
with S10) strongly reduced lux expression in the absence, but
not in the presence, of RBS (Figures 5A and 5B), supporting
a model in which RfaH-CTD:S10 interactions are essential for
translation activation.
We next tested whether this pattern holds for the RfaH-
controlled rfb operon. Consistent with poor translation, expres-
sion of the eighth gene (wbbI) lacking an RBS is nearly abolished
by Rho in the absence, but not presence, of RfaH (Sevostyanova
et al., 2011). The effects of RfaH variants on wbbI expression
were similar to those observedwith the RBS-deficient lux operon
(Figure 5C). The E48A substitution increased wbbI mRNA levels
relative to WT protein 1.6-fold, whereas RfaH-CTD deletion and
I146D substitution decreased them 11- and 7-fold, respec-
tively. L145D, a substitution of another residue at the putative
RfaH-CTD:S10 interface, had a less dramatic but still significant
effect (4-fold). Together, these data argue that RfaH-CTD
mediates efficient expression of translationally challenged
operons that carry ops elements. Two residues that interact
with S10 in NusG-CTD (Burmann et al., 2010) are critical for
this effect, strongly indicating that the b barrel form of RfaH-
CTD establishes similar contacts with S10.
RfaH Interacts with S10 In Vivo
To confirm that RfaH mediates S10 interaction in vivo, we used
targeted ChIP-chip to compare the relative levels of S10
(NusE), RNAP, RfaH, NusG, and NusB on the rfb operon (Fig-
ure 5D) to those on a conventional protein-coding operon, atp
(Figure 5E), an rRNA operon (Figure 5F), and two sRNA genes,
Figure 5. RfaH-CTD Is Required for Effects on Translation and May Interact with S10
(A and B) Reporter assays using the translation-competent (A) (pIA955) and defective (B) (pIA1087) ops-lux operon constructs, which differ in sequence 5 nt
upstream from the ATG codon, GAGGA and CACAC, respectively. The assays were performed in the rfaH deletion strain transformed with plasmids encoding
RfaH variants under control of the PBAD promoter, as before (Belogurov et al., 2010). The results are expressed as luminescence corrected for the cell densities of
individual cultures.
(C) Expression of rfb operon (top) was evaluated by qRT-PCR. Total RNAwas isolated fromDrfaH cells expressingWT or an altered RfaH variant, and the absolute
amount of wbbI mRNA was measured. In (A)–(C), errors (±SD) were calculated from three independent experiments.
(D–G) ChIP-chip analysis of the protein-coding rfb and atp operons and noncoding rrnE, rnpB, and ssrA genes, performed as described previously (Belogurov
et al., 2009; Mooney et al., 2009a) with probe sets for the rfb (D), atp (E), rrnE (F), ssrA (G), and rnpB (G) transcription units (TUs). Cy3 signal (IP) from the DNA
immunoprecipitated with monoclonal antibodies to RNAP (b subunit), NusA, or HA epitope tag on NusG or polyclonal antibodies to RfaH, NusE (S10), or NusB
was divided by Cy5 signal (input) from unenriched DNA collected prior to immunoprecipitation. The data for each target were quantile normalized against each
other so that relative signal ratios could be compared and plotted on a log2 scale. The ratios of average NusE/RNAP and NusG/RNAP signals were 1.1 and
0.47 (rfb), 1.1 and 0,88 (atp), 0.98 and 1.1 (rrnE), 0.35 and 0.45 (rnpB), and 0.36 and 0.55 (ssrA).
See also Figure S5.
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Figure 6. RfaH-CTD:S10 Interface
(A) Mapping of the titration induced [1H,15N]-HSQC chemical shift changes (Ddnorm [ppm] > 0.2, red; > 0.1, orange; and > 0.04, yellow) on structures of the
NusB:S10 complex (dark and light gray, respectively; PDB-ID 3D3B (Luo et al., 2008)) and RfaH-CTD (gray). Strongly affected residues (sticks; carbon, red;
oxygen, red; nitrogen, blue; sulfur, yellow) are shown. Gray sphere in S10 denotes the Ca position of S46, which in this construct replaces residues 46–67 of the
WT S10 (Luo et al., 2008).
298 Cell 150, 291–303, July 20, 2012 ª2012 Elsevier Inc.
rnpB and ssrA (Figure 5G). Relative to RNAP signal, rfb, atp, and
rrnE all exhibited high levels of S10, whereas the untranslated
sRNA genes exhibited much lower levels of S10. The S10 signal
on rfb likely reflects ribosomes interacting with RfaH because
both NusG and NusB, the known partner of S10 in antitermina-
tion complexes (Squires and Zaporojets, 2000), were absent.
In contrast, rrnE, on which NusB:S10-containing antitermination
complexes are known to form, gave significant NusB signal.
Because NusG is specifically excluded from the rfb operon by
RfaH (Belogurov et al., 2009), these data suggest that S10 may
instead interact with RfaH.
To detect the RfaH:S10 interaction in cellular extracts, we
analyzed proteins that associate with RfaH-CTD using formalde-
hyde crosslinking followed by mass spectrometry. 30S ribo-
somal proteins and S10 in particular were preferentially bound
to RfaH-CTD, along with TraT, an outer-membrane lipoprotein
encoded by the RfaH-controlled tra operon (Figure S7).RfaH:CTD Forms a Complex with S10 In Vitro
To distinguish between direct and indirect RfaH-CTD:S10 inter-
actions, we turned to in vitro analysis. Direct RfaH-CTD:S10
contact was observed by NMR and implied by gel filtration
(Figures S6D–S6F). Determination of the Kd for the RfaH-
CTD:S10:NusB complex was not possible with NMR data
(Kd for NusG-CTD:S10:NusB: 50 mM; Burmann et al., 2010).
Chemical shift mapping of RfaH-CTD:S10:NusB interactions
suggests that RfaH-CTD and NusG-CTD have similar binding
modes (Figure 6). The interaction surface is composed of
a hydrophobic pocket of helix a2 and strands b1 and b4 of
S10 and the loops between strands b1/b2, b3/b4, and residues
from strand b4 of RfaH-CTD. RfaH-CTD thus forms a plug that
fits into an S10 pocket, in analogy to the NusG:S10 complex
(Burmann et al., 2010). The high similarity between these two
interaction surfaces, together with sequence homology in the
S10-binding regions of RfaH and NusG (Figure S6), indicate
similar functional contacts between the b barrel CTDs and
S10 and suggest that RfaH-CTD can bind to free as well as
ribosome-bound S10 because its binding site remains acces-
sible when it is part of the ribosome. Although we could only
detect RfaH-CTD:S10 interactions at high concentrations
in vitro, our observations that substitutions in RfaH located at
the interface confer defects in vivo (Figure 5C) support a func-
tional role of this contact in the cell and suggest that stable
interaction occurs in the context of an RfaH-modified TEC
and the ribosome.
To address the possibility that the interaction with S10 might
trigger domain opening in full-length RfaH, we titrated unlabeled
RfaH into 15N-labeled S10 (Figure S6G). Interaction of the two
proteins could not be observed, clearly demonstrating that S10
recognizes RfaH-CTD in the b barrel fold only and that presence(B) Surface representation of the structures shown in (A). Orientations relative
corresponding interaction surface of the NusB:S10:NusG-CTD complex (Burman
(C) [1H,15N]-HSQC-derived chemical shift changes versus sequence position. (Le
the S10 ribosome-binding loop are indicated by a break on the sequence axis
significance level of Ddnorm[ppm] = 0.04; red bars, signals disappearing upon co
See also Figures S6 and S7.of S10 alone does not induce RfaH domain release or RfaH-CTD
refolding.
DISCUSSION
RfaH strongly inhibits Rho-dependent termination via antipaus-
ing modification of RNAP and exclusion of the Rho cofactor
NusG (Sevostyanova et al., 2011). Here, we present evidence
that RfaH also binds to the ribosome to dramatically activate
translation. This activity requires complete refolding of RfaH-
CTD from a helix into b barrel conformation. We show that
RfaH-CTD, which folds as an a helix in the full-length, domain-
closed form of the protein, folds as a b barrel when expressed
separately. Even more strikingly, in full-length RfaH, RfaH-CTD
refolds to a b barrel when its interaction with RfaH-NTD is weak-
enedbyanE48Ssubstitutionorwhen thedomain linker is broken.
In vivo, the domain separation is induced by RfaH interactions
with the ops DNA element presented in the context of the TEC
whereinRfaH-NTDexchanges its contactswith theCTD for those
with the b0 clamp helices domain of RNAP. The dramatic confor-
mational switch of RfaH-CTD enables RNAP coupling to a ribo-
some by RfaH, thus activating translation and blocking Rho-
dependent termination in RfaH-controlled operons (Figure 7).
RfaH as a Transcription Antiterminator
RfaH was initially described as a transcription factor that targets
a group of ops-containing genes in enteric bacteria. Although
some of these genes encode important commensal functions
(e.g., LPS core biosynthesis), most RfaH-controlled genes are
essential for virulence (e.g., a-hemolysin and capsule biosyn-
thesis). RfaH dramatically increases expression of distal genes
in these operons by supporting RNAP readthrough termination
signals. RfaH has thus been termed an antiterminator.
Antitermination modification of RNAP is particularly important
in eukaryotes, in which transcribed units can consist of many
nucleotides, and in foreign (e.g., phage) bacterial genes, which
are poorly translated and subject to polarity control by joint
action of Rho and NusG. All genes that are controlled by RfaH
have been acquired through horizontal transfer and are thus
highly sensitive to NusG-enhanced Rho-dependent termination.
Consistently, RfaH’s main activity is to inhibit Rho (Belogurov
et al., 2009), and here it has to work against NusG, which is
present in E. coli in concentrations >100-fold higher than RfaH
is (Li et al., 1993; Belogurov et al., 2009).
Antitermination was thought to explain all transcription activa-
tion effects by RfaH. We showed that RfaH antagonizes Rho
activity by two mechanisms, both mediated by the RfaH-NTD.
First, RfaH competes with NusG for binding to the b0 clamp
helices and excludes NusG from the TEC both in vivo and
in vitro, thereby reducing Rho efficiency. Second, RfaH inhibitsto (A) (NusB:S10) and Figure 1 (RfaH-CTD) are indicated. Inserts show the
n et al., 2010).
ft) S10 chemical shift changes on titration with RfaH-CTD; missing residues of
. (Right) RfaH-CTD chemical shift changes on titration with S10. Dotted line,
mplex formation. Triangles, unassigned residues.
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Figure 7. Model for Multifaceted Activation of Gene Expression by RfaH
In RfaH-controlled operons, the ops element is located within 100 nt upstream of a GTG predicted (based on protein sequence analysis) to serve as a translation
start codon. In absence of RfaH (left), NusG-NTD binds to the b0 clamp helices (dark gray cylinder), and NusG-CTD interacts with Rho (purple) to terminate
transcription by RNAP (gray). In the rfb operon, Rho decreases expression of distal genes by 800-fold (Sevostyanova et al., 2011). When present (right), RfaH
binds to elongating RNAP at the ops site and reduces Rho effect to 2-fold. This strong antipolar activity depends on the coordinated action of both RfaH domains
becoming separated during recruitment. Unaltered RfaH-NTD binds to the b0 clamp helices to reduce transcriptional pausing and exclude NusG-NTD from
binding to RNAP; both activities inhibit Rho-dependent termination. The refolded RfaH-CTD recruits the 30S subunit (bound to the initiator tRNA) via direct
contacts with S10. Thus, the tethered translation initiation complex scans the mRNA lacking a strong Shine-Dalgarno (SD) element for another yet unknown start
signal. Recruitment of the ribosome directly increases translation and indirectly decreases Rho-dependent termination by shielding mRNA from Rho.formation of the paused state, which is a target for Rho. The first
mechanism is unique for RfaH, whereas the second antipausing
mechanism is conserved from bacteria to humans among
NusG-like proteins that share the binding site on the TEC
and the molecular mechanism of antipausing modification
(Hirtreiter et al., 2010; Martinez-Rucobo et al., 2011; Sevostya-
nova et al., 2011).
Although a combination of these two mechanisms could
explain large effects of RfaH on the expression of some genes,
we observe much smaller effects on transcription in vitro (3- to
4-fold) or on RBS+ lux reporter activity in vivo (7- to 10-fold).
Our current study provides a solution to this puzzle: we show
that RfaH dramatically stimulates expression of the lux reporter
when its translation is compromised and that RfaH-CTD is
required for this effect. In retrospect, control at the level of trans-
lation could be expected in the case of RfaH-regulated operons
that have many features suggesting poor translation, from
a weak translation start context to a very high fraction of rare
codons (Figure S3).
RfaH as a Translation Factor
Deletion of RBS is sufficient to make the expression of a heterol-
ogous lux operon strongly dependent on RfaH (Figure 5). This
suggests that RfaH can facilitate active recruitment of the ribo-
some to nascent mRNA as it emerges from an RfaH-bound
RNAP. RfaH remains bound to the TEC until it reaches the
operon end. Thus, if RfaH maintains contacts with the ribosome
after recruitment, it will ensure tight transcription-translation
coupling throughout the entire operon, thereby blocking Rho-
dependent termination and possibly inhibiting ribosome pausing
and release. Analysis of RfaH-dependent operons is consistent
with this model. For example, the first gene in the rfb operon
(Figure S3) lacks a canonical SD element and starts with a sub-
optimal GUG, whereas several downstream genes are transla-
tionally coupled, suggesting that, once the first ribosome loads300 Cell 150, 291–303, July 20, 2012 ª2012 Elsevier Inc.on the mRNA, it could complete translation without dissociating
from the message.
How is 30S recruitment mediated by RfaH in the absence of a
match between the mRNA and 16S rRNA? We show that RfaH
directly interacts with S10 and that substitutions at the RfaH:S10
interface compromise activation of translation-deficient lux
operon and RfaH-dependent rfb operon. Structural modeling
shows that this interaction may occur in the context of either
30S or 70S assemblies, consistent with both initial recruitment
and retention of the ribosome. RfaH may induce a conforma-
tional change that allows 30S recruitment ormay simply increase
the local concentration of 30S in the vicinity of mRNA.
The distance between ops element and presumed start codon
of the first gene is similar (100 nt) among RfaH targets, but it is
yet unknown how the ribosome-loading site is determined or
whether translation starts at a unique site. We do not yet know
whether RfaH (and NusG, which is typically recruited to RNAP
further downstream; Belogurov et al., 2009) could also facilitate
ribosome binding to suboptimal sites in the middle of an operon.
RfaH-CTD as a Metamorphous Domain
We here suggest that transcription-translation coupling may be
the major mechanism by which RfaH activates gene expression,
as compared to its ancient and universally conserved ability to
reduce RNAP pausing. This coupling requires a dramatic rear-
rangement of RfaH-CTD, and RfaH-CTD stands out from a group
of metamorphic proteins (Andreeva and Murzin, 2006; Tokuriki
and Tawfik, 2009) as it undergoes an unprecedented complete
switch from an all-a to an all-b fold, extending the classic view
(Anfinsen, 1973) that a given amino acid sequence under defined
environmental conditions leads to a unique three-dimensional
(3D) structure. Indeed, comparison of sequentially nearly iden-
tical, rationally designed proteins reveals that only a few amino
acid residues encode the secondary structure (Alexander
et al., 2009; Bryan and Orban, 2010).
Structural interconversion between a helix and b sheet was
mainly observed with artificial peptides by varying the solution
conditions (Minor and Kim, 1996) or in myoglobin, where it was
possible to induce a fold consisting of b strand fibrils into
all-a-helical myoglobin under nonnative conditions (Fa¨ndrich
et al., 2001). In neurodegenerative diseases like Alzheimer’s
and the prion-related diseases, structural rearrangement leads
to formation of amyloid aggregates that consist nearly exclu-
sively of b strands (Greenwald and Riek, 2010; Surewicz and
Apostol, 2011).
Very few refolding events that lead to alternate functions, and
none as dramatic as for RfaH, have been described. Lymphotac-
tin (Ltn) exists in two active conformations under physiological
conditions—as amonomer with a chemokine fold and as a dimer
with a b sandwich fold—and the interconversion is induced by
reorganization of an N-terminal loop to form a b strand interac-
tion while the C-terminal a helix becomes unstructured (Tuinstra
et al., 2008). The mitotic arrest deficiency 2 protein (Mad2) also
exists in two conformations that are 70% identical; C-terminal
andN-terminal regions form an additional b hairpin as a key inter-
action partner binding site in a closed state, stabilizing it
compared to the open, noninteracting form (Luo et al., 2004).
The chloride intracellular channel 1 protein (CLIC1) is able to
adopt two distinct conformations in solution, depending on its
oxidation state: the formation of a disulfide-bridge mediates
the conversion of the N-terminal a/b/a sandwich into a three
a helix bundle (Littler et al., 2010).
Although these proteins undergo significant conformational
changes, the dramatic all-a to all-b switch observed with RfaH-
CTD is so far unique in its magnitude, as well as in its functional
consequences. Importantly, both states of RfaH-CTD play
essential roles in regulation of gene expression. As an a-helical
hairpin, RfaH-CTD masks the RNAP-binding surface until RfaH
recognizes the ops site, of which fewer than 20 exist in the
E. coli genome; this autoinhibition is essential to avoid interfer-
ence with NusG. RfaH domain interaction is disrupted on RfaH-
NTD recruitment to the TEC, thus enabling RfaH-CTD structural
transformation. In the b barrel conformation, RfaH-CTD estab-
lishes contacts with S10, favoring ribosome recruitment. This
plasticity of RfaH-CTD raises the question of whether or not the
diverse interactions reported for the NusG-like CTDs of eukary-
otic NusG and RfaH homologs (Chen et al., 2009; Schneider
et al., 2006; Zhou et al., 2009b) are all mediated by a b fold (Klein
et al., 2011; Werner and Grohmann, 2011). This view is based on
the fact that all NusG-like CTDs contain a KOW motif (Kyrpides
et al., 1996) that is embedded in an all-b-fold as in NusG or
SPT5 proteins (Knowlton et al., 2003; Mooney et al., 2009b;
Reay et al., 2004; Steiner et al., 2002), ribosomal proteins L24
(Ban et al., 2000), eL26, and eL27 (Ben-Shem et al., 2010), and
the tudor domain of human SMN protein (Selenko et al., 2001).
Some of these interactions may deserve closer inspection with
respect to the possibility of a native a-to-b fold transition. Indeed,
the ability of a protein to adopt two antagonistic foldswith diverse
roles is a very elegant solution to employ a single amino acid
sequence for different uses. It would be surprising if this
approach would not be applied by other regulatory proteins in
the NusG family or other protein families to expand their reper-
toire of functions and interaction partners.EXPERIMENTAL PROCEDURES
Expression and purification of proteins, experimental details of LC/MS/MS
measurements, transcription pause assays, NMR measurements, and struc-
ture determination protocols are described in the Extended Experimental
Procedures.
Quantitative Real-Time PCR
To test the effect of mutations in RfaH on its natural target, we analyzed the
expression level of wbbI, the eighth gene in rfb operon, by qRT-PCR. Vectors
encoding different RfaH variants under control of Ptrc promoter were trans-
formed into IA149 (DrfaH) strain (Belogurov et al., 2010) grown with agitation
at 37C to OD600 = 0.6, and protein expression was induced by addition of
0.2 mM IPTG for 2 hr. Total RNA was isolated by phenol extraction and treated
with DNaseI from Epicenter (Madison, WI, USA) according to manufacturer’s
instructions. Control PCR with specific oligos without RT-step was performed
to ensure the absence of DNA contamination. Total RNA samples (1 mg)
were added to the one-step qRT-PCR reaction mix from QIAGEN (Valencia,
CA, USA) and analyzed in triplets on CFX96 System from Biorad (Hercules,
CA, USA). For each sample, at least three repeats in two independent exper-
iments (starting from cell growth and RNA isolation) were performed as
described (Sevostyanova et al., 2011).
In Vivo Reporter Assay
Plasmids carrying RfaH variants were cotransformed with a reporter vector
carrying lux operon with or without RBS (pIA955 or pIA1087, respectively)
into IA149 strain and plated on selective media (100 mg/ml carbenicillin,
50 mg/ml chloramphenicol). Single colonies were inoculated into 3 ml of LB
media supplemented with antibiotics and incubated at 37C. After 6 hr of
growth, cultures were diluted into fresh LB containing antibiotics and 0.5%
glucose to OD6000.01 and were allowed to grow for an additional 2 hr.
Expression of RfaH variants was induced by addition of IPTG to 0.2 mM for
3 hr. Luminescence was measured in 200 ml aliquots in triplicates on FLUOstar
OPTIMA plate reader (BMG LABTECH GmbH, Offenburg, Germany) and
normalized by cell density.
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